- Abstracts
- Audio/video scripts
- Book chapters
- Case studies
- CD-ROMs/DVDs
- CE/CME programs
- Journal manuscripts
- Journal supplements
- Monographs
|
- Newsletters
- Objection handlers
- Patient education
- Promotional
- Posters
- PowerPoint™ presentations
- Product backgrounders
- Training manuals
- Website content
|
Download the latest version of Acrobat to view these files. 
Writing Experience
1991-present – Rx-Press – Sole proprietor
Profitably generating both educational and promotional writing projects for the health care industry. Clients include Novartis, GlaxoSmithKline, Boehringer Ingelheim, Sanofi Pasteur, Shire, Genentech, Genzyme, Roche, Takeda, Schering and others.
The writing services of Rx-Press include peer-reviewed journal articles and supplements, review articles, PowerPoint presentations, monographs, patient education, sales rep training, and all other aspects of medical communication, promotion, and education.
Book chapters
Colorectal cancer
Rheumatoid arthritis
Continuing education
Asthma/allergy
Poison ivy
Psychiatry - Adult ADHD
Journal articles
Insulin - Psychological effects
Interleukin-12 - Therapeutic targets
Journal supplements
Migraine
Bowl of Hygeia
Monograph
ADHD-Depression
Managed Care Issues for Osteoarthritis of the Knee
Newsletters
Adult ADHD
Antiplatelet therapy for secondary stroke
Antiangiogenesis – Pancreatic carcinoma
Antiangiogenesis – Colorectal carcinoma
PowerPoint™ presentations
Antiretroviral
Narcolepsy
Training manual
Opioid dependence
Manuscript title and publication information
The following list contains a selection of published manuscripts for which Rx-Press provided editorial assistance, that is, structure, research, organization, writing, referencing, and other activities necessary to get the manuscript into publishable form.
Adler L, Gasbarro RD. Diagnosis and treatment issues in adult ADHD. Amer Psychiatry News. 2008;1 (special report):1-8.
Arnold W, Fullerton DS, Holder S, May CS. Viscosupplementation: managed care issues for osteoarthritis of the knee. J Manag Care Pharm. 2007;13(suppl):S3-19.
Arrieta AC, Bradley JS. Empiric use of cefepime in the treatment of serious urinary tract infections in children. Pediatr Infect Dis J. 2001;20:350-5.
Barrie AM III, Plevy SE. The interleukin-12 family of cytokines: Therapeutic targets for inflammatory disease mediation. Clin Applied Immunol Rev. 2005;e225-40.
Blumer JL, Reed MD, Knupp C. Review of the pharmacokinetics of cefepime in children. Pediatr Infect Dis J. 2001;20:337-42.
Bradley JS, Arrieta A. Empiric use of cefepime in the treatment of lower respiratory tract infections in children. Pediatr Infect Dis J. 2001;20:343-9.
Campos C. Narrowing the cultural divide in diabetes mellitus care: a focus on improving cultural competency to better serve Hispanic/Latino populations. Insulin. 2006;1:70-6.
Cannon CP. The endocannabinoid system: a new approach to control cardiovascular disease. Clin Cornerstone. 2005;7:17-26.
Cannon E. Aligning patient care and asthma treatment guidelines. Am J Manag Care. 2005;11(14 Suppl):S416-21.
Cohen C. First-line treatment in HIV: many paths to success. J Acquir Immune Defic Syndr. 2003;33:S29-38.
Cohen M, Diez JE, Levine GN, et al; ACC; AHA. Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report – III. J Invasive Cardiol. 2007;19:525-38.
Comella CL, Jankovic J, Brin MF. Use of botulinum toxin type A in the treatment of cervical dystonia. Neurology. 2000;55(12 Suppl 5):S15-21.
Cooksley WG, Piratvisuth T, Lee SD, et al. Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B. J Viral Hepat. 2003;10:298-305.
Dardick K. Educating travelers about malaria: dealing with resistance and patient noncompliance. Cleve Clin J Med. 2002; 69:469-79.
Davila GW. Transdermal oxybutynin: a new treatment for overactive bladder. Expert Opin Pharmacother. 2003;4:2315-24.
DelBello MP, Versavel M, Ice K, Keller D, Miceli J. Tolerability of oral ziprasidone in children and adolescents with bipolar mania, schizophrenia, or schizoaffective disorder. J Child Adolesc Psychopharmacol. 2008;18:491
Dmochowski RR, Nitti V, Staskin D, Luber K, Appell R, Davila GW. Transdermal oxybutynin in the treatment of adults with overactive bladder: combined results of two randomized clinical trials. World J Urol. 2005;23:263-70.
Dyke CM, Jennings LK, Maier G, Andreou C, Daly R, Tamberella MR 3rd. Preoperative platelet inhibition with eptifibatide during coronary artery bypass grafting with cardiopulmonary bypass. J Cardiovasc Pharmacol Ther. 2007;12:54-60.
Fivenson DP. The mechanisms of action of nicotinamide and zinc in inflammatory skin disease. Cutis. 2006;77(1 Suppl):5-10.
Gasbarro R. Negative pressure wound therapy: a clinical review. Wounds. 2007;19(suppl):1-8.
Hernandez JD, Wesseling K, Salusky IB. Role of parathyroid hormone and therapy with active vitamin D sterols in renal osteodystrophy. Semin Dial. 2005;18:290-5.
Hillier SL. How birth control changes your vaginal ecosystem. Fem Patient. 2006;(suppl):13-16.
Jensen JT, Nelson AL, Costales AC. Subject and clinician experience with the levonorgestrel-releasing intrauterine system. Contraception. 2008;77:22-9.
Jones SE. Antiaromatase agents: evolving role in adjuvant therapy. Clin Breast Cancer. 2002;3:33–42.
Kirshner HS. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician. Int J Clin Pract. 2007;61:1739-48.
Krishnan SM, Stark JG. Multiple daily-dose pharmacokinetics of lisdexamfetamine dimesylate in healthy adult volunteers. Curr Med Res Opin. 2008;24:33-40.
Lasseter KC, Dilzer SC, Vargas R, Waldman S, Noveck RJ. Pharmacokinetics and safety of ebastine in patients with impaired hepatic function compared with healthy volunteers: a phase I open-label study. Clin Pharmacokinet. 2004;43:121-9.
Malik P, Balaban DH, Thompson WO, Galt DJ. Randomized study comparing two regimens of oral sodium phosphates solution versus low-dose polyethylene glycol and bisacodyl. Dig Dis Sci. 2008; 10.1007/s10620-008-0420-x.
Messerli FH, Oparil S, Feng Z. Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension. Am J Cardiol. 2000;86:1182-7.
Moyle GJ. Protease inhibitor-sparing regimens: new evidence strengthens position. J Acquir Immune Defic Syndr. 2003;33:S17-25.
Murphy RL. Reviving protease inhibitors: new data and more options. J Acquir Immune Defic Syndr. 2003;33:S43-52.
Navarro RP. Asthma treatment guidelines: how do we measure up? Am J Manag Care. 2005;11(14 Suppl):S422-6.
Neutel JM. The importance of 24-h blood pressure control. Blood Press Monit. 2001;6:9-16.
Parker LM. Sequencing of hormonal therapy in postmenopausal women with metastatic breast cancer. Clin Ther. 2002;24 (Suppl C):C43-57.
Pi-Sunyer FX. The relation of adipose tissue to cardiometabolic risk. Clin Cornerstone. 2006;8(suppl 4):S14-23.
Powderly WG. Limitations of current HIV therapies: opportunities for improvement. J Acquir Immune Defic Syndr. 2003;33:S7-12.
Ratner PH, Lim JC, Georges GC. Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis. The Ebastine Study Group. J Allergy Clin Immunol. 2000;105(6 Pt 1):1101-7.
Saez-Llorens X, O'Ryan M. Cefepime in the empiric treatment of meningitis in children. Pediatr Infect Dis J. 2001;20:356-61.
Schild AF. Maintaining vascular access: the management of hemodialysis arteriovenous grafts. J Vasc Access. 2010;11:92-9.
Sebba A. Tocilizumab: the first interleukin-6-receptor inhibitor. Am J Health Syst Pharm. 2008;65:1413-8.
Sinha SK, Lacaze-Masmonteil T, Valls i Soler A, et al; for Surfaxin Therapy Against Respiratory Distress Syndrome Collaborative Group. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Pediatrics. 2005;115:1030-8.
Stotland NL. Overcoming psychological barriers in insulin therapy. Insulin. 2006;1:38-45.
Tellier G, Niederman MS, Nusrat R, Patel M, Lavin B. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia. J Antimicrob Chemother. 2004;54:515-23.
Vinik AI. The metabolic basis of atherogenic dyslipidemia. Clin Cornerstone. 2005;7:27-35
Watts RL, Raiser CD, Stover NP, et al. Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson's disease. J Neural Transm Suppl. 2003;215-27.
Weir MR. The role of multiple drug therapy for controlling hypertension in African Americans. J Clin Hypertens (Greenwich). 2000;2:99-108.